Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px
Document › Details

ACEA Biosciences, Inc.. (4/2/14). "Press Release: ACEA Biosciences Introduces the NovoCyte Flow Cytometer. Exceptional Performance at a Low Investment". San Diego, CA.

Organisations Organisation ACEA Biosciences Inc.
  Organisation 2 OLS Omni Life Science GmbH & Co. KG
  Today Omni Life Science (OLS) (Group)
  Group Omni Life Science (OLS) (Group)
Products Product NovoCyte™ flow cytometer
  Product 2 xCELLigence System
Index term Index term Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Germany

Up to Fifteen Parameter Detection with Enhanced Sensitivity and Resolution

ACEA Biosciences, a pioneer in the development of high performance cell analysis platforms for life science research known for their xCELLigence® platform, introduces the NovoCyte flow cytometer. The NovoCyte system addresses a full range of multi-parameter cellular analysis research needs with high performance at a low investment cost, making it more attainable for researchers to have benchtop flow cytometers in their labs. The system enables detection of up to fifteen parameters with enhanced sensitivity and resolution and is customizable to meet researchers' current and future needs with options to add-on at a later date. The NovoCyte flow cytometer is available with one to three laser options, exchangeable filters, multiple sampling options and flexible analysis formats. Operation is intuitive with automated instrument maintenance functions and advanced data analysis capabilities for greater usability. Other important features enhance usability such as a fixed optical alignment, 24-bit detection dynamic range with no need for PMT voltage adjustment, accurate volumetric-based cell counting, pressure sensors to monitor fluidic status in real-time, and automatic cleaning and de-contamination processes.

"Flow cytometry is a powerful tool for cell analysis and yet the cost and complexity of systems can limit accessibility for researchers," said Xiaobo Wang, Ph.D., Chief Technology Officer, ACEA Biosciences. "With the NovoCyte system, researchers have a new option to advance their studies with the best combination of performance, usability and cost."

ACEA also developed the NovoExpress™ software which is intuitive and easy to use. Flexible analysis templates and plotting tools offer enhanced data analysis efficiency.

The NovoCyte system will be on display at the ACEA Bioscience booth (#710) at the American Association for Cancer Research (AACR) Annual Meeting 2014 April 5-9, 2014 in San Diego, California.

For more information, please visit
A high resolution photo of the NovoCyte system can be downloaded here and the Auto Sampler is available here.

Media Contact: Reena Patel | | O:(919) 381-6702 | M:(919) 744-7556


About ACEA Biosciences

Founded in 2002, ACEA Biosciences, Inc. (ACEA) is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. Researchers are advancing their studies utilizing 1,000+ placed instruments for broad and diverse applications. The technology has been cited in over 500 peer reviewed publications. ACEA's xCELLigence® impedance-based, label-free, real time cell analysis system and NovoCyte™ flow cytometers are used in pre-clinical drug discovery and development, toxicity, safety pharmacology, and basic academic research. For more information visit

Record changed: 2019-08-15


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Agilent (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top